Entering the Indonesian market is an exciting opportunity for foreign manufacturers and exporters. With over 270 million consumers and a fast-growing regulated product sector, Indonesia is difficult to ignore.
However, one decision made early in the market entry process often becomes the source of serious legal and commercial headaches: assigning a local distributor as the official NIE (Nomor Izin Edar) holder.
Understanding the full scope of product license holder risks is not just important; it is essential before signing any agreement with a local partner.
What Is an NIE and Why Does It Matter?
The Nomor Izin Edar (NIE) is the official marketing authorization number issued by Indonesia’s National Agency of Drug and Food Control (Badan Pengawas Obat dan Makanan, or BPOM), or by the Ministry of Health (Kementerian Kesehatan), depending on the product category.
Without a valid NIE, no product can be legally imported, marketed, or sold in Indonesia.
Under Indonesian law, specifically referencing BPOM Regulation No. 26 of 2018 on Electronically Integrated Licensing Services, and the Minister of Health Regulation No. 62 of 2017 on Medical Device Marketing Authorization, foreign manufacturers are not permitted to hold the NIE directly under their own name.
The NIE must be issued to an Indonesian legal entity, which in most cases becomes a local distributor or a licensed importer.
This legal requirement is where the problems begin for many foreign companies.
The Core Problem: Distributor vs License Holder Is Not the Same Thing
Many foreign exporters assume that appointing a distributor and assigning an NIE holder are two separate, manageable arrangements. In practice, they are not.
When a distributor becomes the NIE holder, that entity does not merely sell the product — it legally owns the registration.
This creates a fundamental conflict of interest. The NIE holder has legal responsibility for the product’s compliance, recall obligations, post-market surveillance, and label accuracy.
But the holder also controls whether the product can be renewed, transferred, or even sold at all within Indonesian territory.
The difference between a distributor and a license holder is not just administrative. It is a difference in power, legal standing, and long-term control over a brand. Foreign companies that conflate the two roles often discover this only after a dispute has begun.
Risk #1: License “Hijacking” by the Distributor
One of the most significant product license holder risks that foreign manufacturers face in Indonesia is what practitioners informally call “license hijacking.” This occurs when a distributor holds the NIE for a product and, upon a breakdown in the business relationship, refuses to cooperate with a transfer of that registration to a new party.
Because the NIE is legally registered under the distributor’s name, the foreign manufacturer has no direct authority to instruct BPOM or the Ministry of Health to transfer the license.
Any variation or transfer application must be initiated and signed by the current holder. If the current holder is uncooperative, the process comes to a complete standstill.
In some cases, distributors have been known to use this leverage to demand renegotiation of commercial terms, lower purchase pricing, or extended exclusivity periods.
In more extreme situations, a hostile distributor may attempt to register similar or competing products using the same product files and technical documentation, essentially exploiting the knowledge gained during the registration process to the detriment of the original brand owner.
Indonesian law under Law No. 36 of 2009 on Health does provide criminal sanctions for distributing products without a valid license, but it does not easily resolve disputes over who should hold an existing license when both parties have a contractual claim.
Risk #2: The Nightmare of Changing Distribution Partners
Even in situations where a distributor has not acted in bad faith, the practical difficulty of transferring the NIE to a new holder is often severely underestimated. This is one of the most common product license holder risks that foreign companies encounter after their initial market entry.
The transfer of product license in Indonesia is a formal regulatory process. It is not simply a matter of updating a business contract.
The new holder must qualify as an eligible registration holder (holding the appropriate distributor license, such as IDAK for medical devices or an import license from BPOM), must submit a full set of administrative and technical documentation, and must obtain regulatory approval before the transfer takes effect.
During this transition period, which can take months depending on product category and BPOM workload, the product may not be legally distributed under the new entity’s name. Sales operations may need to pause. Revenue is disrupted. If the old distributor has already stopped cooperating, the situation can become legally complex and commercially damaging.
This dependency on a single distributor’s goodwill and administrative cooperation creates a structural weakness in the foreign company’s market position.
Companies that recognize this risk early can take steps to protect themselves through smarter structuring from the outset.
Risk #3: Structural Dependency That Grows Over Time
The third major category of product license holder risks is perhaps the most insidious because it develops gradually. As a distributor accumulates more registrations on behalf of a foreign brand, the foreign manufacturer becomes progressively more dependent on that single entity.
Each new product registered under the distributor’s name adds another layer of entanglement. Over time, the distributor holds not just one NIE but an entire portfolio of the foreign company’s product registrations.
The cost of replacing that distributor becomes exponentially higher with each registration added. This dynamic often leads to situations where the foreign manufacturer feels unable to exit a poorly performing distribution relationship, not because of commercial inertia, but because of regulatory captivity.
This structural dependency can also affect the foreign company’s ability to respond to market opportunities. Introducing new products, updating formulations, expanding into new channels, or rebranding all require the cooperation and administrative engagement of the current NIE holder.
If the relationship has deteriorated, every regulatory action becomes a negotiation.
The Indonesian Regulatory Framework Behind These Risks
To understand why these product license holder risks are structural rather than anecdotal, it helps to look at the regulations that govern them.
Under the Minister of Health Regulation No. 62 of 2017 (for medical devices) and BPOM Regulation No. 24 of 2017 (for pharmaceutical products, as amended), the NIE is issued to the registering entity and tied to that entity’s legal credentials.
The regulations require the holder to maintain post-market obligations, including vigilance reporting, recall cooperation, and BPOM inspection compliance.
For medical devices specifically, the holder must possess a valid IDAK (Izin Distribusi Alat Kesehatan), or Medical Device Distribution License. This requirement means that the foreign manufacturer cannot simply transfer the NIE to an unqualified entity overnight.
The new holder must already hold the appropriate operational licenses, which takes time to establish and verify.
Government Regulation No. 32 of 2017 also establishes the fee structures for registration-related transactions, which become relevant when calculating the true cost of a license transfer process.
These regulations, while logical from a public health oversight perspective, create conditions where an informed distributor can use regulatory procedure as a tool for commercial leverage.
Distributor vs License Holder: The Smarter Approach
The solution that experienced foreign companies and regulatory advisors consistently recommend is the separation of the NIE holder role from the commercial distributor role.
Rather than allowing the commercial distributor to hold the product registration, the foreign manufacturer can work with a neutral, professional third-party license holder — sometimes referred to as a regulatory service provider or a “dummy distributor” arrangement — that holds the NIE independently of whoever is distributing the product commercially.
Under this model, the transfer of product license from one commercial distributor to another does not require NIE transfer at all.
The NIE remains with the neutral holder throughout. The commercial distributor operates under an authorized distribution arrangement from the NIE holder, not as the holder itself.
This separation of functions gives the foreign brand owner the flexibility to change commercial partners, adjust pricing and distribution strategies, and manage regulatory renewals without being held hostage by any single distributor’s cooperation.
How ProductRegistrationIndonesia Supports Foreign Exporters
Foreign companies navigating these challenges do not have to figure it out alone.
Product Registration Indonesia specializes in providing exactly the kind of structured, independent license holder services that protect foreign brand owners from the product license holder risks described in this article.
Rather than leaving the product’s regulatory fate in the hands of a commercial partner whose interests may not always align, working with a dedicated regulatory service provider is a practical and legally sound approach.
What to Do Before Entering the Indonesian Market
Any foreign manufacturer or exporter considering the Indonesian market should address these questions before signing any distributor agreement:
Who will hold the NIE, and what happens to it if the distribution relationship ends? Is there a contractual mechanism that guarantees NIE transfer cooperation? Is the commercial distributor also the NIE holder, and if so, what leverage does that give them? Has the foreign company consulted with a qualified Indonesian regulatory advisor about structuring the arrangement correctly from the start?
These are not just legal formalities. They are strategic decisions that determine how much freedom the foreign company will have in its Indonesian operations for years to come.
The Right Time to Act Is Before Problems Begin
It is far easier and less expensive to structure an NIE arrangement correctly at the outset than to unwind a problematic one later.
The transfer of product license process in Indonesia is time-consuming, and disputes between distributors and foreign manufacturers over NIE control can drag on for years, during which time the product may be unable to legally enter the market.
Companies that take product license holder risks seriously before entering Indonesia are the ones that build durable, scalable, and dispute-resistant market positions.
Those that treat the NIE holder question as a minor administrative detail often pay a significant price for that oversight.
Professional, independent, and experienced regulatory support can make the difference between owning your market position and losing it to a registration dispute. Contact us now for a confidential consultation.
Frequently Asked Questions (FAQ)
Q1: What is the NIE (Nomor Izin Edar) and who can hold it in Indonesia?
The NIE is the official marketing authorization number that allows a product to be legally imported, sold, and distributed in Indonesia. It is issued by BPOM (for food, cosmetics, supplements, traditional medicines, and pharmaceuticals) or the Ministry of Health (for medical devices). Under Indonesian law, the NIE must be held by an Indonesian legal entity. Foreign manufacturers without an Indonesian subsidiary or qualified local entity cannot hold the NIE directly under their own name, which is why they must appoint either a commercial distributor or a professional third-party license holder.
Q2: What are the main product license holder risks when using a commercial distributor as the NIE holder?
The three primary product license holder risks are: first, license hijacking, where a distributor refuses to cooperate with an NIE transfer during a commercial dispute, effectively holding the registration as leverage; second, the practical difficulty of changing distribution partners once the NIE is tied to a single entity, which can disrupt market access for months; and third, growing structural dependency, where each additional product registered under the same distributor makes it progressively harder and more costly to exit the arrangement.
Q3: What is the difference between a distributor and a license holder in Indonesia?
In Indonesia, a commercial distributor is the entity responsible for selling and physically distributing a product within the market. A license holder (pemegang izin edar) is the entity that legally owns the product’s NIE registration and bears all regulatory responsibilities, including post-market surveillance, recall cooperation, and BPOM compliance. While these roles are often assigned to the same entity by default, they do not have to be. Separating the two roles by using a professional third-party license holder is a recognized and legally sound strategy that preserves the foreign manufacturer’s control.
Q4: How does the transfer of product license work in Indonesia, and how long does it take?
The transfer of product license (alih pemegang izin edar) is a formal regulatory process that requires both the current NIE holder and the receiving entity to submit documentation to BPOM or the Ministry of Health. The receiving entity must hold the appropriate operational licenses (such as IDAK for medical devices). The process involves administrative review, technical documentation verification, and regulatory approval, which can take several months depending on product category and the completeness of submitted documents. If the current holder is uncooperative, the process may be delayed indefinitely, which underscores the importance of choosing the right NIE holder structure from the beginning.
Q5: Is there a legal way for a foreign company to maintain control over its NIE in Indonesia without setting up a full local subsidiary?
Yes. Foreign companies can work with a qualified regulatory service provider that acts as the professional NIE holder on their behalf. This arrangement, sometimes referred to as a neutral or independent license holder, keeps the NIE separate from the commercial distributor. The foreign manufacturer grants an authorized distribution agreement to commercial distributors who work under the neutral holder’s umbrella. This model is legally recognized under Indonesian regulations and is widely used by international manufacturers of medical devices, cosmetics, food supplements, and pharmaceutical products who wish to protect their market position while maintaining the flexibility to change commercial partners without regulatory disruption. ProductRegistrationIndonesia offers exactly this type of service, providing foreign companies with a professional, compliant, and commercially neutral NIE holding solution.
